Perfil del fabricante
American Regent, Inc.
Compañía farmacéutica4 productos registrados
4
productos registrados
19.384
notificaciones totales
4
retiradas registradas
63,4%
graves en total
Productos
mostrando 4 de 4
| Producto | Aprobado | Notificaciones ↓ | Señal principal | Retiradas |
|---|---|---|---|---|
| 1978 | 8660 | depósito del producto | 0 | |
| 2013 | 4574 | Hipofosfatemia | 1 | |
| — | 4574 | Hipofosfatemia | 0 | |
| 1986 | 1576 | inflamación del lecho ungueal | 3 |
Historial de retiradas · 11 registradas
| Fecha | Clase | Motivo | Empresa |
|---|---|---|---|
| 16 abr 2026 | III | Labeling: Missing Label | American Regent, Inc. |
| 18 abr 2025 | II | Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance. | American Regent, Inc. |
| 18 abr 2025 | II | Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance. | American Regent, Inc. |
| 11 nov 2024 | II | Presence of Particulate Matter: Potential for glass delamination from the vials. | American Regent, Inc. |
| 11 nov 2024 | II | Presence of Particulate Matter: Potential for glass delamination from the vials. | American Regent, Inc. |
| 11 nov 2024 | II | Presence of Particulate Matter: Potential for glass delamination from the vials. | American Regent, Inc. |
| 14 may 2024 | II | Lack of Assurance of Sterility. | American Regent, Inc. |
| 18 jun 2019 | II | Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance. | Premier Pharmacy Labs Inc |
| 12 jun 2019 | II | Lack of Assurance of Sterility | Infusion Options, Inc. |
| 24 feb 2015 | II | Presence of particulate. | SCA Pharmaceuticals |
| 14 nov 2014 | II | Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin. | Attix Pharmaceuticals |
Clase I = probabilidad razonable de daño grave · Clase II = temporal o reversible · Clase III = improbable que cause daño.
Estado de registro
Algunos productos de American Regent, Inc. no están registrados por la FDA para uso humano. Para las sustancias no registradas (péptidos, SARM sin registro humano) no existe ningún proveedor legítimo para uso humano. La ausencia de una vía de aprovisionamiento es la información de seguridad.